Medical care of kidney transplant recipients after the first posttransplant year.

Kidney transplantation is the treatment of choice for patients with ESRD. Despite improvements in short-term patient and graft outcomes, there has been no major improvement in long-term outcomes. The use of kidney allografts from expanded-criteria donors, polyoma virus nephropathy, underimmunosuppression, and incomplete functional recovery after rejection episodes may play a role in the lack of improvement in long-term outcomes. Other factors, including cardiovascular disease, infections, and malignancies, also shorten patient survival and therefore reduce the functional life of an allograft. There is a need for interventions that improve long-term outcomes in kidney transplant recipients. These patients are a unique subset of patients with chronic kidney disease. Therefore, interventions need to address disease progression, comorbid conditions, and patient mortality through a multifaceted approach. The Kidney Disease Outcomes Quality Initiative from the National Kidney Foundation, the European Best Practice Guidelines, and the forthcoming Kidney Disease: Improving Global Outcomes clinical practice guidelines can serve as a cornerstone of this approach. The unique aspects of chronic kidney disease in the transplant recipient require the integration of specific transplant-oriented problems into this care schema and a concrete partnership among transplant centers, community nephrologists, and primary care physicians. This article reviews the contemporary aspects of care for these patients.

[1]  R. Balshaw,et al.  New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  M. Suthanthiran,et al.  Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.

[3]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[4]  G. Choukroun,et al.  Benefits of Erythropoietin in Renal Transplantation , 2005, Transplantation.

[5]  P. Roderick,et al.  Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review , 2004, Transplantation.

[6]  R. Oberbauer Calcineurin Inhibitor Withdrawal from Sirolimus‐Based Therapy in Kidney Transplantation: A Systematic Review of Randomized Trials , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  H. Malluche,et al.  Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. , 2003, Journal of the American Society of Nephrology : JASN.

[8]  T. Louis,et al.  Immunosuppression withdrawal in renal transplantation. , 2000, Transplantation proceedings.

[9]  F. Locatelli,et al.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.

[10]  B. Kasiske,et al.  Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[11]  R. Wüthrich,et al.  Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  E. Jones,et al.  Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  A. Levey,et al.  THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION , 1995, Transplantation.

[14]  H. E. Hansen,et al.  The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.

[15]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[16]  G. Opelz,et al.  Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. , 1998, Kidney international.

[17]  A. Melk,et al.  Rethinking chronic allograft nephropathy: the concept of accelerated senescence. , 1999, Journal of the American Society of Nephrology : JASN.

[18]  K. Scott,et al.  Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  Christopher P. Johnson,et al.  Post-transplant renal function in the first year predicts long-term kidney transplant survival. , 2002, Kidney international.

[20]  L. Ruilope,et al.  Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study. , 1994, Transplantation proceedings.

[21]  A. Djamali,et al.  Outcomes in kidney transplantation. , 2003, Seminars in nephrology.

[22]  A. Nagler,et al.  INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA , 2000, Transplantation.

[23]  G. Mayer,et al.  Proteinuria in the transplanted patient. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  M. Schnitzler Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  G. Tydén,et al.  Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). , 1998, Transplantation.

[26]  J. Adamson,et al.  IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  J. Schold,et al.  Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies? , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[28]  H. Goldschmidt,et al.  Malignancy in renal transplantation. , 2004, Journal of the American Society of Nephrology : JASN.

[29]  M. Ghoneim,et al.  WEIGHT GAIN AFTER RENAL TRANSPLANTATION IS A RISK FACTOR FOR PATIENT AND GRAFT OUTCOME , 2004, Transplantation.

[30]  F. Cosio,et al.  Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. , 2002, Kidney international.

[31]  S. Paraskevas,et al.  Factors associated with improvement in deceased donor renal allograft function in the 1990s. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  V. D’Agati,et al.  Angiotensin converting enzyme inhibition in chronic allograft nephropathy , 2002, Transplantation.

[33]  H. Auchincloss,et al.  Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. , 2000, Journal of the American Society of Nephrology : JASN.

[34]  U. Eisenberger,et al.  The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[36]  D. Heisey,et al.  Influence of kidney function to the impact of acute rejection on long‐term kidney transplant survival , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[37]  C. Newstead Recurrent disease in renal transplants. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  A. Matas,et al.  Life satisfaction in renal transplant recipients: preliminary results from the transplant learning center. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  R. Gans,et al.  Metabolic Syndrome Is Associated with Impaired Long‐term Renal Allograft Function; Not All Component criteria Contribute Equally , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  H. Gül,et al.  Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. , 2004, Clinical biochemistry.

[41]  D. Heisey,et al.  Obesity as a risk factor following renal transplantation. , 1995, Transplantation.

[42]  M. Arias,et al.  Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  J. Pirsch,et al.  Blood pressure control in kidney transplantation: therapeutic implications , 2004, Journal of Human Hypertension.

[44]  D. Heisey,et al.  Erythropoietin therapy may retard progression in chronic renal transplant dysfunction. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  Glomerulonephritis recurrence in the renal graft. , 2001, Journal of the American Society of Nephrology : JASN.

[46]  H. Meier‐Kriesche,et al.  Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  A. Levey,et al.  Demographics and trends in overweight and obesity in patients at time of kidney transplantation. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  R. Wolfe,et al.  Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes. , 1997, Transplantation.

[49]  R. Colvin,et al.  Chronic allograft nephropathy , 2003, Current opinion in nephrology and hypertension.

[50]  G. Remuzzi,et al.  Proteinuria and phenotypic change of proximal tubular cells. , 2003, Journal of the American Society of Nephrology : JASN.

[51]  A. Hartmann,et al.  Hypertension after kidney transplantation: are treatment guidelines emerging? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  S. Lemeshow,et al.  Patient survival after renal transplantation III: the effects of statins. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  E. Shane,et al.  Osteoporosis after solid organ transplantation. , 2005, The Journal of clinical endocrinology and metabolism.

[54]  D. Nicol,et al.  Obesity is Associated with Worsening Cardiovascular Risk Factor Profiles and Proteinuria Progression in Renal Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[55]  D. Coleman,et al.  New human papovavirus (B.K.) isolated from urine after renal transplantation. , 1971, Lancet.

[56]  G. Klintmalm,et al.  Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[57]  M. Sayegh,et al.  Transplantation 50 years later--progress, challenges, and promises. , 2004, The New England journal of medicine.

[58]  C. Kendziorski,et al.  Disease progression and outcomes in chronic kidney disease and renal transplantation. , 2003, Kidney international.

[59]  I. Macdougall,et al.  Intravenous iron sucrose: establishing a safe dose. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[60]  R. Rodger,et al.  Hypertension, antihypertensive agents and outcomes following renal transplantation , 2005, Clinical transplantation.

[61]  I. Holme,et al.  Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. , 2004, Kidney international.

[62]  R. Rubin,et al.  Infection in organ-transplant recipients. , 1998, The New England journal of medicine.

[63]  P. Randhawa,et al.  Effect of Leflunomide and Cidofovir on Replication of BK Virus in an In Vitro Culture System , 2005, Transplantation.

[64]  H. Meier‐Kriesche,et al.  The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. , 2002, Transplantation.

[65]  D. Ellison,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[66]  D. Abramowicz,et al.  Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[67]  Philip F Halloran,et al.  Banff 2003 Meeting Report: New Diagnostic Insights and Standards , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[68]  P. Friend,et al.  Two‐year incidence of malignancy in sirolimus‐treated renal transplant recipients: results from five multicenter studies * , 2004, Clinical transplantation.

[69]  Y. Becker,et al.  Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients1 , 2003, Transplantation.

[70]  Cees van Kooten,et al.  Chronic renal allograft rejection: pathophysiologic considerations. , 2005, Kidney International.

[71]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[72]  I. Holme,et al.  Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[73]  H. Pilmore,et al.  Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy , 2002, Clinical transplantation.

[74]  A. Levin Cystatin C, Serum Creatinine, and Estimates of Kidney Function: Searching for Better Measures of Kidney Function and Cardiovascular Risk , 2005, Annals of Internal Medicine.

[75]  S. Palmer,et al.  Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[76]  J. Alexander,et al.  Gastric bypass in morbidly obese kidney transplant recipients. , 1996, Clinical transplantation.

[77]  G. Opelz,et al.  Improved Long‐Term Outcomes After Renal Transplantation Associated with Blood Pressure Control , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[78]  T. Theruvath,et al.  Strategies to improve long-term outcomes after renal transplantation. , 2002, The New England journal of medicine.

[79]  G. Jhangri,et al.  The stability of the glomerular filtration rate after renal transplantation is improving. , 2003, Journal of the American Society of Nephrology : JASN.

[80]  R. Zietse,et al.  PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL , 2001, Transplantation.

[81]  D. Greenwood,et al.  Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention , 2004, Circulation.

[82]  B. Maes,et al.  Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[83]  J. Trotter,et al.  Immunosuppression: Evolution in Practice and Trends, 1994–2004 , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[84]  K. Rootwelt,et al.  Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. , 2001, Transplantation.

[85]  N. Perico,et al.  Routine renin-angiotensin system blockade in renal transplantation? , 2002, Current opinion in nephrology and hypertension.

[86]  R. Foley,et al.  Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. , 2003, Journal of the American Society of Nephrology : JASN.

[87]  S. Head,et al.  De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[88]  G. Knoll,et al.  The Burden of Chronic Kidney Disease in Renal Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[89]  H. Meier‐Kriesche,et al.  Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 , 2003, Transplantation.

[90]  J. Briggs Causes of death after renal transplantation. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[91]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[92]  J F Burdick,et al.  International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. , 1993, Kidney international.

[93]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[94]  E. Shane,et al.  Osteoporosis after organ transplantation. , 1998, The American journal of medicine.

[95]  B. Kiberd,et al.  Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. , 2005, Transplantation proceedings.

[96]  J. Fink,et al.  Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. , 2001, Kidney international.

[97]  F. Berthoux SECTION IV: Long-term management of the transplant recipient , 2002 .

[98]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[99]  R L Kormos,et al.  Does transplantation produce quality of life benefits? A quantitative analysis of the literature. , 1997, Transplantation.

[100]  N. Muirhead Erythropoietin and renal transplantation. , 1999, Kidney international. Supplement.

[101]  J. Fink,et al.  Late Calcineurin Inhibitor Withdrawal as a Strategy to Prevent Graft Loss in Patients with Suboptimal Kidney Transplant Function , 2004, American Journal of Nephrology.

[102]  R. Oberbauer,et al.  SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10 , 2001, Transplantation.

[103]  P. Keown,et al.  Improving quality of life--the new target for transplantation. , 2001, Transplantation.

[104]  R. Colvin,et al.  Campath‐1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[105]  D. Hricik,et al.  Comparative Effects of Sirolimus and Mycophenolate Mofetil on Erythropoiesis in Kidney Transplant Patients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[106]  M. Schnitzler,et al.  Incidence and predictors of myocardial infarction after kidney transplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[107]  J. Soulillou,et al.  Immunosuppressive drugs and the risk of cancer after organ transplantation. , 2005, The New England journal of medicine.

[108]  M. Schnitzler,et al.  Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[109]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[110]  F. Valderrábano,et al.  Quality of life in end-stage renal disease patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[111]  M. Zand,et al.  Management of Hyperlipidemia in the Stable Solid Organ Transplant Recipient , 2001 .

[112]  Markus Exner,et al.  Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. , 2002, Journal of the American Society of Nephrology : JASN.

[113]  A. Kazory,et al.  Predicting coronary heart disease in renal transplant recipients: a prospective study. , 2004, Kidney international.

[114]  P. Terasaki,et al.  Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[115]  B. Kasiske,et al.  Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[116]  N. Basri,et al.  Diabetes mellitus after renal transplantation. , 1992, Transplantation proceedings.

[117]  T. Paavonen,et al.  Sirolimus‐Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[118]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[119]  J. Fishman BK virus nephropathy--polyomavirus adding insult to injury. , 2002, The New England journal of medicine.

[120]  L. Agodoa,et al.  Late urinary tract infection after renal transplantation in the United States. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[121]  Junchao Cai,et al.  Humoral theory of transplantation: further evidence. , 2005, Current opinion in immunology.

[122]  R. Montgomery,et al.  Consensus Opinion from the Antibody Working Group on the Diagnosis, Reporting, and Risk Assessment for Antibody-Mediated Rejection and Desensitization Protocols , 2004, Transplantation.

[123]  P. Lang,et al.  Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. , 1996, Transplantation.

[124]  W. Bennett,et al.  Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. , 1996, Kidney international.

[125]  B. Kasiske,et al.  Surrogate Markers for Long‐Term Renal Allograft Survival , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[126]  S. Alexander,et al.  Late Post‐transplant Anemia in Adult Renal Transplant Recipients. An Under‐recognized Problem? , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[127]  K. Kubota,et al.  Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. , 2005, Kidney international.

[128]  N. Greenspan,et al.  Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.

[129]  P. Terasaki,et al.  Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. , 2003, Clinical transplants.

[130]  D. Dunn,et al.  Early versus late acute renal allograft rejection: impact on chronic rejection. , 1993 .

[131]  R. Ouseph,et al.  Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). , 1999, Transplantation.

[132]  R. Parasuraman,et al.  Rapid Resolution of Proteinuria of Native Kidney Origin Following Live Donor Renal Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[133]  R. Foley,et al.  Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. , 2002, Journal of the American Society of Nephrology : JASN.

[134]  B. Kasiske,et al.  Hypertension after kidney transplantation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[135]  M. Joffe,et al.  Arterial hypertension and renal allograft survival. , 2000, JAMA.

[136]  E. Ryan,et al.  Prevention of Infection in Adult Travelers After Solid Organ Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[137]  B. Kasiske,et al.  Hyperlipidemia in solid organ transplantation. , 1997, Transplantation.

[138]  S. Palmer,et al.  Interventions for preventing bone disease in kidney transplant recipients. , 2005, The Cochrane database of systematic reviews.

[139]  W. Leslie,et al.  Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate , 2003, Transplantation.

[140]  Ethan M Balk,et al.  Erratum: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (Annals of Internal Medicine (2003) 139 (137-147)) , 2003 .

[141]  P. Terasaki,et al.  Predictive Value of HLA Antibodies and Serum Creatinine in Chronic Rejection: Results of a 2-year Prospective Trial , 2005, Transplantation.

[142]  J. Alexander,et al.  DIABETIC PATIENTS ON DIALYSIS SHOULD BE TRANSPLANTED , 2004 .

[143]  L. Schiffmann,et al.  Effects of Parathyroidectomy on Renal Allograft Survival , 2004, Kidney and Blood Pressure Research.

[144]  W. Bennett,et al.  Cyclosporine nephrotoxicity. , 2003, Seminars in nephrology.

[145]  R. Gans,et al.  Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[146]  Philip F Halloran,et al.  Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.

[147]  M. Fishbein,et al.  Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[148]  W. Winkelmayer,et al.  Pharmacoepidemiology of anemia in kidney transplant recipients. , 2004, Journal of the American Society of Nephrology : JASN.

[149]  B. Kasiske,et al.  Long‐Term Deterioration of Kidney Allograft Function , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[150]  P. Marchetti New-onset diabetes after transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[151]  B. Kasiske,et al.  Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[152]  R. Wolfe,et al.  Long-term survival in renal transplant recipients with graft function. , 2000, Kidney international.

[153]  T. Warner,et al.  Tertiary hyperparathyroidism after renal transplantation: surgical strategy. , 1998, Surgery.

[154]  A. Kazory,et al.  One‐Year Post‐Transplant Weight Gain is a Risk Factor for Graft Loss , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[155]  Bertram L Kasiske,et al.  New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.

[156]  J. Preiksaitis,et al.  Guidelines for the prevention and management of infectious complications of solid organ transplantation , 2004 .

[157]  A. Kliger,et al.  Treatment of Osteoporosis and Osteopenia in Long‐term Renal Transplant Patients with Alendronate , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[158]  J. Curtis,et al.  Variables affecting weight gain in renal transplant recipients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[159]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[160]  A. Kaider,et al.  Parameters associated with chronic renal transplant failure. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[161]  B. Brenner,et al.  Why is proteinuria an ominous biomarker of progressive kidney disease? , 2004, Kidney international. Supplement.

[162]  Lee Hebert,et al.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[163]  J. Millis,et al.  Leflunomide for polyomavirus type BK nephropathy. , 2005, The New England journal of medicine.

[164]  P. Vereerstraeten,et al.  Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. , 2000, Transplantation.

[165]  L. Gesualdo,et al.  Sirolimus for Kaposi's sarcoma in renal-transplant recipients. , 2005, The New England journal of medicine.

[166]  S. Hariharan,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[167]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[168]  A. Levey Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[169]  M. Denton,et al.  Recurrent and de novo glomerulonephritis in the renal allograft. , 2000, Seminars in nephrology.

[170]  B. Kasiske,et al.  Risk factors for cancer in renal transplant recipients. , 1999, Transplantation.

[171]  H. Meier‐Kriesche,et al.  Renal transplantation: a half century of success and the long road ahead. , 2004, Journal of the American Society of Nephrology : JASN.

[172]  J. Torras,et al.  Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. , 1996, Journal of the American Society of Nephrology : JASN.

[173]  R. Wolfe,et al.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.

[174]  C.,et al.  New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.

[175]  R. Muehrer,et al.  PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Life After Transplantation: New Transitions in Quality of Life and Psychological Distress , 2005, Seminars in dialysis.

[176]  J. Schold,et al.  Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[177]  A. Matas,et al.  Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis , 2002, Clinical transplantation.

[178]  F. Schena,et al.  Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. , 2004, Journal of the American Society of Nephrology : JASN.

[179]  E. Briganti,et al.  Risk of renal allograft loss from recurrent glomerulonephritis. , 2002, The New England journal of medicine.

[180]  S. Bartuś,et al.  Noncompliance in organ transplant recipients. , 1990, Transplantation.

[181]  T. Lehnert,et al.  Malignancy after renal transplantation. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[182]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[183]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[184]  N. Perico,et al.  Performance of Different Prediction Equations for Estimating Renal Function in Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[185]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[186]  R. Mannon Polyomavirus nephropathy: what have we learned? , 2004, Transplantation.

[187]  R. Jindal,et al.  Obesity and kidney transplantation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[188]  T. Klimkait,et al.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.

[189]  P. Kuo,et al.  A novel approach to the treatment of chronic allograft nephropathy. , 1997, Transplantation.

[190]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[191]  G. Borm,et al.  Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[192]  M. Schnitzler,et al.  Guidelines for the treatment and management of new‐onset diabetes after transplantation 1 , 2005, Clinical transplantation.

[193]  J. Dipiro,et al.  RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1 , 2000, Transplantation.